Publications

  1. Kwon JY, Daoud N, Ghoz H, Yataco ML, Farraye FA. Efficacy of a two-dose hepatitis B vaccination with a novel immunostimulatory sequence adjuvant (Heplisav-B) on patients with chronic liver disease: a retrospective study. Transl Gastroenterol Hepatol. 2023; 8:8 Epub 2023 Jan 25
    View PubMed
  2. Yataco ML, Bowman AW, Keaveny AP. Management of the Incidental Liver Lesion. Am J Gastroenterol. 2021 May 1; 116 (5):855-861
    View PubMed
  3. Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ, REGENERATE Study Investigators. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2019 Dec 14; 394(10215):2184-2196. Epub 2019 Dec 05.
    View PubMed
  4. Croome KP, Lee DD, Croome S, Nakhleh RE, Abader Sedki Senada P, Livingston D, Yataco M, Taner CB. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort. Liver Transpl. 2019 Oct; 25 (10):1533-1540 Epub 2019 July 08
    View PubMed
  5. Chaney AJ, Yataco ML. The Emerging Role of Nurse Practitioners and Physician Assistants in Liver Transplantation. Liver Transpl. 2019 Jul; 25 (7):1105-1109 Epub 2019 May 27
    View PubMed
  6. Aniskevich S, Chadha RM, Peiris P, Taner CB, Torp KL, Thomas CS, Yataco ML, Pai SL. Intra-operative predictors of postoperative Takotsubo syndrome in liver transplant recipients-An exploratory case-control study. Clin Transplant. 2017 Nov; 31 (11) Epub 2017 Sept 14
    View PubMed
  7. Palmer WC, Lee D, Burns J, Croome K, Rosser B, Patel T, Keaveny AP, Pungpapong S, Satyanarayana R, Yataco M, Nakhleh R, Musto KR, Canabal AM, Turnage AK, Hodge DO, Nguyen JH, Harnois DM. Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center. Ann Hepatol. 2017 May - Jun; 16 (3):402-411
    View PubMed
  8. Palmer WC, Lee D, Burns J, Croome K, Rosser B, Patel T, Keaveny AP, Pungpapong S, Satyanarayana R, Yataco M, Nakhleh R, Musto KR, Canabal AM, Turnage AK, Hodge DO, Nguyen JH, Harnois DM. Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center. Ann Hepatol. 2017 May - Jun; 16 (3):402-411
    View PubMed
  9. Yataco M, Patel T. Hepatology highlights. Ann Hepatol. 2016 Sep - Oct; 15 (5):660-661
    View PubMed
  10. Yataco M, Cowell A, David W, Keaveny AP, Taner CB, Patel T. Predictors and impacts of hospital readmissions following liver transplantation. Ann Hepatol. 2016 May-Jun; 15 (3):356-62
    View PubMed
  11. Yataco M, Cowell A, David W, Keaveny AP, Taner CB, Patel T. Predictors and impacts of hospital readmissions following liver transplantation. Ann Hepatol. 2016 May - Jun; 15 (3):356-362
    View PubMed
  12. Bargehr J, Trejo-Gutierrez JF, Patel T, Rosser B, Aranda-Michel J, Yataco ML, Taner CB. Preexisting atrial fibrillation and cardiac complications after liver transplantation. Liver Transpl. 2015 Mar; 21: (3)314-20.
    View PubMed
  13. Yataco ML, Difato T, Bargehr J, Rosser BG, Patel T, Trejo-Gutierrez JF, Pungpapong S, Taner CB, Aranda-Michel J. Reversible non-ischaemic cardiomyopathy and left ventricular dysfunction after liver transplantation: a single-centre experience. Liver Int. 2014 Jul; 34(6):e105-10. Epub 2014 Mar 15.
    View PubMed
  14. Harnois DM, Yataco ML, Nakhleh RE. Recurrence of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis after transplantation. Clin Liver Dis (Hoboken). 2014 Apr; 3 (4):90-92 Epub 2014 Apr 28
    View PubMed
  15. Bargehr J, Trejo-Gutierrez JF, Rosser BG, Patel T, Yataco ML, Pungpapong S, Taner CB, Aranda-Michel J. Liver transplantation in patients with atrial fibrillation. Transplant Proc. 2013 Jul-Aug; 45(6):2302-6.
    View PubMed
  16. Pungpapong S, Aqel BA, Koning L, Murphy JL, Henry TM, Ryland KL, Yataco ML, Satyanarayana R, Rosser BG, Vargas HE, Charlton MR, Keaveny AP. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl. 2013 Jul; 19 (7):690-700 Epub 2013 June 03
    View PubMed
  17. Yataco M, Bonatti H, Machicao V, Mendez J, Stauffer J, Nguyen J, Ghabril M, Ghabril M, Aranda-Michel J, Dickson R. Long term survival and complications after liver transplantation in patients with chronic hepatitis B. Ann Transplant. 2010 Apr-Jun; 15 (2):27-34
    View PubMed
  18. Yataco ML, Dickson RC, Bonatti H, Aranda-Michel J, Mendez J, Ghabril M, Nguyen J. Dual hepatitis virus infections in liver transplant: case report and a review of the literature. Clin Transplant. 2009 Mar-Apr; 23(2):282-8. Epub 2009 Dec 18.
    View PubMed
  19. Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl. 2007 Dec; 13(12):1717-27.
    View PubMed